Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQHealth CareBiotechnologySnapshot 2026-11-05
$27.00-20.70%
Close 2026-11-05 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-05
QuarterlyIQ Insights · ARQT
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | 508.7 | 376.1 | 196.5 | 59.6 | 3.7 | 0.0 | 0.0 |
| Total Revenues | 508.7 | 376.1 | 196.5 | 59.6 | 3.7 | — | — |
| Cost of Revenues | 44.9 | 36.7 | 19.1 | 5.0 | 0.8 | 0.0 | — |
| Operating Expenses & Income | |||||||
| Selling, General & Admin | 334.8 | 274.6 | 229.4 | 185.1 | 122.1 | 61.0 | — |
| R&D Expenses | 93.9 | 77.1 | 76.4 | 110.6 | 182.4 | 145.6 | 115.3 |
| Operating Income | 35.2 | (12.2) | (128.4) | (241.1) | (301.6) | (206.5) | (136.6) |
| Earnings from Continuing Operations | |||||||
| Interest Expense | — | 12.1 | 27.2 | 29.7 | 15.7 | 0.0 | 0.0 |
| Other Non-Operating Income / Expenses | — | — | — | — | (9.8) | 0.2 | 1.0 |
| Income Tax Expense | 0.9 | 1.2 | 0.6 | 3.1 | 0.0 | 0.0 | 0.0 |
| Net Income | |||||||
| Net Income | 29.9 | (16.1) | (140.0) | (262.1) | (311.5) | (206.4) | (135.7) |
| Per Share | |||||||
| Basic EPS | 0.23 | (0.13) | (1.16) | (3.78) | (5.66) | (4.18) | (3.80) |
| Diluted EPS | 0.22 | (0.13) | (1.16) | (3.78) | (5.66) | (4.18) | (3.80) |
| Revenue per Share | 3.72 | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 131.0 | 127.2 | 121.0 | 69.3 | 55.0 | 49.4 | 35.7 |
| Diluted Weighted Avg Shares | 136.8 | 127.2 | 121.0 | 69.3 | 55.0 | 49.4 | 35.7 |
| Supplemental | |||||||
| EBIT | 35.2 | (12.2) | (128.4) | (241.1) | (301.6) | (206.5) | (136.6) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.